Literature DB >> 11889248

Parkin mutations in a patient with hemiparkinsonism-hemiatrophy: a clinical-genetic and PET study.

P P Pramstaller1, G Künig, K Leenders, M Kann, K Hedrich, P Vieregge, C G Goetz, C Klein.   

Abstract

The authors describe a 37-year-old woman with early-onset hemiparkinsonism (HP) and ipsilateral body hemiatrophy (HA). Genetic analysis revealed a missense mutation (Arg275Trp) and a duplication of exon 7 of parkin. The complementary metabolic and receptor pattern of PET ligands corresponded to that typically found in idiopathic PD, although tracer binding asymmetry was lacking. Parkin mutations should be considered in HPHA, particularly when there is a younger age at onset and dystonia is an early sign.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889248     DOI: 10.1212/wnl.58.5.808

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes.

Authors:  Eva Reiter; Beatrice Heim; Christoph Scherfler; Christoph Mueller; Michael Nocker; Jean-Pierre Ndayisaba; Wolfgang Loescher; Klaus Seppi; Andrew J Lees; Thomas Warner; Werner Poewe; Gregor K Wenning; Atbin Djamshidian
Journal:  Mov Disord Clin Pract       Date:  2016-01-18

2.  Breakpoint mapping of 13 large parkin deletions/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations.

Authors:  Peter Elfferich; Marja C Verleun-Mooijman; J Anneke Maat-Kievit; Bart P C van de Warrenburg; Wilson F Abdo; Sylvia A Eshuis; Klaus L Leenders; Ad Hovestadt; Jan C M Zijlmans; Jan-Pieter M Stroy; John C van Swieten; Agnita J W Boon; Klaartje van Engelen; Corien C Verschuuren-Bemelmans; Saskia A J Lesnik-Oberstein; Cristina Tassorelli; Leonardo Lopiano; Vincenzo Bonifati; Dennis Dooijes; Rick van Minkelen
Journal:  Neurogenetics       Date:  2011-10-13       Impact factor: 2.660

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.